News
Pharmaceutical Technology on MSN13h
US FDA approves GSK’s Benlysta autoinjector for lupus nephritisThe US Food and Drug Administration (FDA) has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five ...
Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback